• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

二聚体和单体 mGluR 组的神经发育表达谱:与精神分裂症发病机制和治疗的相关性。

Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment.

机构信息

Illawarra Health and Medical Research Institute, Wollongong, New South Wales 2522 Australia.

School of Medicine, Faculty of Science, Medicine and Health, University of Wollongong, Wollongong, NSW 2522 Australia.

出版信息

Sci Rep. 2016 Oct 10;6:34391. doi: 10.1038/srep34391.

DOI:10.1038/srep34391
PMID:27721389
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5056358/
Abstract

Group 1 metabotropic glutamate receptors (mGluR1/mGluR5) play an integral role in neurodevelopment and are implicated in psychiatric disorders, such as schizophrenia. mGluR1 and mGluR5 are expressed as homodimers, which is important for their functionality and pharmacology. We examined the protein expression of dimeric and monomeric mGluR1α and mGluR5 in the prefrontal cortex (PFC) and hippocampus throughout development (juvenile/adolescence/adulthood) and in the perinatal phencyclidine (PCP) model of schizophrenia. Under control conditions, mGluR1α dimer expression increased between juvenile and adolescence (209-328%), while monomeric levels remained consistent. Dimeric mGluR5 was steadily expressed across all time points; monomeric mGluR5 was present in juveniles, dramatically declining at adolescence and adulthood (-97-99%). The mGluR regulators, Homer 1b/c and Norbin, significantly increased with age in the PFC and hippocampus. Perinatal PCP treatment significantly increased juvenile dimeric mGluR5 levels in the PFC and hippocampus (37-50%) but decreased hippocampal mGluR1α (-50-56%). Perinatal PCP treatment also reduced mGluR1α dimer levels in the PFC at adulthood (-31%). These results suggest that Group 1 mGluRs have distinct dimeric and monomeric neurodevelopmental patterns, which may impact their pharmacological profiles at specific ages. Perinatal PCP treatment disrupted the early expression of Group 1 mGluRs which may underlie neurodevelopmental alterations observed in this model.

摘要

1 型代谢型谷氨酸受体(mGluR1/mGluR5)在神经发育中起着重要作用,并与精神疾病有关,如精神分裂症。mGluR1 和 mGluR5 表达为同源二聚体,这对于它们的功能和药理学非常重要。我们研究了在发育过程中(青少年/成年)以及精神分裂症的围产期苯环利定(PCP)模型中,前额叶皮层(PFC)和海马体中二聚体和单体 mGluR1α 和 mGluR5 的蛋白表达。在对照条件下,mGluR1α 二聚体表达在青少年期和成年期之间增加(209-328%),而单体水平保持一致。二聚体 mGluR5 一直稳定表达在所有时间点;单体 mGluR5 存在于青少年中,在青少年期和成年期急剧下降(-97-99%)。mGluR 调节剂 Homer 1b/c 和 Norbin 在 PFC 和海马体中随年龄的增长而显著增加。围产期 PCP 处理显著增加了 PFC 和海马体中青少年二聚体 mGluR5 的水平(37-50%),但降低了海马体 mGluR1α(-50-56%)。围产期 PCP 处理还降低了成年 PFC 中 mGluR1α 二聚体的水平(-31%)。这些结果表明,1 型 mGluR 具有不同的二聚体和单体神经发育模式,这可能会影响它们在特定年龄的药理学特征。围产期 PCP 处理破坏了 1 型 mGluR 的早期表达,这可能是该模型中观察到的神经发育改变的基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/32af2832d7ab/srep34391-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/067204c7237f/srep34391-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/9822aed1e275/srep34391-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/3bbf7d43a2e1/srep34391-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/0274bdbdcb1b/srep34391-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/32af2832d7ab/srep34391-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/067204c7237f/srep34391-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/9822aed1e275/srep34391-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/3bbf7d43a2e1/srep34391-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/0274bdbdcb1b/srep34391-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebdd/5056358/32af2832d7ab/srep34391-f5.jpg

相似文献

1
Neurodevelopmental Expression Profile of Dimeric and Monomeric Group 1 mGluRs: Relevance to Schizophrenia Pathogenesis and Treatment.二聚体和单体 mGluR 组的神经发育表达谱:与精神分裂症发病机制和治疗的相关性。
Sci Rep. 2016 Oct 10;6:34391. doi: 10.1038/srep34391.
2
Differential distribution of group I metabotropic glutamate receptors during rat cortical development.I 型代谢型谷氨酸受体在大鼠皮层发育过程中的差异分布。
Cereb Cortex. 2002 Jun;12(6):625-38. doi: 10.1093/cercor/12.6.625.
3
Ontogeny of non-NMDA glutamate receptors in rat barrel field cortex: I. Metabotropic receptors.大鼠桶状皮质中非NMDA谷氨酸受体的个体发生:I. 促代谢型受体
J Comp Neurol. 1997 Sep 15;386(1):16-28.
4
Regulation of Metabotropic Glutamate Receptor Internalization and Synaptic AMPA Receptor Endocytosis by the Postsynaptic Protein Norbin.通过突触后蛋白 Norbin 调节代谢型谷氨酸受体内化和突触 AMPA 受体胞吞作用。
J Neurosci. 2022 Feb 2;42(5):731-748. doi: 10.1523/JNEUROSCI.1037-21.2021. Epub 2021 Dec 14.
5
Developmental and sensory-dependent changes of phosphoinositide-linked metabotropic glutamate receptors.
J Comp Neurol. 1997 Dec 29;389(4):577-83. doi: 10.1002/(sici)1096-9861(19971229)389:4<577::aid-cne3>3.0.co;2-y.
6
Alterations of Group I mGluRs and BDNF Associated with Behavioral Abnormity in Prenatally Stressed Offspring Rats.与产前应激子代大鼠行为异常相关的I组代谢型谷氨酸受体和脑源性神经营养因子的改变
Neurochem Res. 2015 May;40(5):1074-82. doi: 10.1007/s11064-015-1565-6. Epub 2015 Apr 18.
7
A postmortem analysis of NMDA ionotropic and group 1 metabotropic glutamate receptors in the nucleus accumbens in schizophrenia.精神分裂症患者伏隔核中 NMDA 离子型和第 1 组代谢型谷氨酸受体的死后分析。
J Psychiatry Neurosci. 2018 Mar;43(2):102-110. doi: 10.1503/jpn.170077. Epub 2017 Oct 6.
8
Enhancement of social novelty discrimination by positive allosteric modulators at metabotropic glutamate 5 receptors: adolescent administration prevents adult-onset deficits induced by neonatal treatment with phencyclidine.代谢型谷氨酸 5 受体正变构调节剂增强社会新颖性辨别:青春期给药可预防新生期氯胺酮处理引起的成年期缺陷。
Psychopharmacology (Berl). 2013 Feb;225(3):579-94. doi: 10.1007/s00213-012-2845-3. Epub 2012 Sep 16.
9
Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation.精神分裂症中 mGluR5 及其内源性调节因子 Norbin、Tamalin 和 Preso1 的改变:朝向 mGluR5 失调模型。
Acta Neuropathol. 2015 Jul;130(1):119-29. doi: 10.1007/s00401-015-1411-6. Epub 2015 Mar 17.
10
Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia.精神分裂症患者前额叶皮质和纹状体中代谢型谷氨酸受体蛋白的表达
Synapse. 2005 Sep 1;57(3):123-31. doi: 10.1002/syn.20164.

引用本文的文献

1
Transcriptomic and Proteomic Changes in the Brain Along with Increasing Phenotypic Severity in a Rat Model of Neonatal Hyperbilirubinemia.新生儿高胆红素血症大鼠模型中,随着表型严重程度增加大脑中的转录组和蛋白质组变化
Int J Mol Sci. 2025 Jun 28;26(13):6262. doi: 10.3390/ijms26136262.
2
The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia.精神分裂症中强迫症症状的神经生物学基础,治疗抵抗性精神分裂症的转化问题。
Biomolecules. 2023 Aug 5;13(8):1220. doi: 10.3390/biom13081220.
3
Neurodevelopment and early pharmacological interventions in Fragile X Syndrome.

本文引用的文献

1
Molecular evidence of synaptic pathology in the CA1 region in schizophrenia.精神分裂症 CA1 区突触病变的分子证据。
NPJ Schizophr. 2016 Jun 29;2:16022. doi: 10.1038/npjschz.2016.22. eCollection 2016.
2
Alteration by p11 of mGluR5 localization regulates depression-like behaviors.p11对代谢型谷氨酸受体5(mGluR5)定位的改变调节抑郁样行为。
Mol Psychiatry. 2015 Dec;20(12):1546-56. doi: 10.1038/mp.2015.132. Epub 2015 Sep 15.
3
Shifting towards a model of mGluR5 dysregulation in schizophrenia: Consequences for future schizophrenia treatment.
脆性X综合征的神经发育与早期药物干预
Front Neurosci. 2023 Aug 2;17:1213410. doi: 10.3389/fnins.2023.1213410. eCollection 2023.
4
Altered GABAergic, glutamatergic and endocannabinoid signaling is accompanied by neuroinflammatory response in a zebrafish model of social withdrawal behavior.在社会退缩行为的斑马鱼模型中,γ-氨基丁酸能、谷氨酸能和内源性大麻素信号的改变伴随着神经炎症反应。
Front Mol Neurosci. 2023 May 22;16:1120993. doi: 10.3389/fnmol.2023.1120993. eCollection 2023.
5
Dysregulated Signaling at Postsynaptic Density: A Systematic Review and Translational Appraisal for the Pathophysiology, Clinics, and Antipsychotics' Treatment of Schizophrenia.突触后密度的失调信号:精神分裂症的病理生理学、临床和抗精神病药物治疗的系统评价和转化评估。
Cells. 2023 Feb 10;12(4):574. doi: 10.3390/cells12040574.
6
Targeting metabotropic glutamate receptors for the treatment of depression and other stress-related disorders.靶向代谢型谷氨酸受体治疗抑郁症和其他与应激相关的障碍。
Neuropharmacology. 2021 Sep 15;196:108687. doi: 10.1016/j.neuropharm.2021.108687. Epub 2021 Jun 25.
7
Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective.Group 1 代谢型谷氨酸受体在神经和精神疾病中的作用机制及前景展望
Neuroscientist. 2022 Oct;28(5):453-468. doi: 10.1177/10738584211021018. Epub 2021 Jun 4.
8
Effect of Aggressive Experience in Female Syrian Hamsters on Glutamate Receptor Expression in the Nucleus Accumbens.雌性叙利亚仓鼠的攻击经历对伏隔核中谷氨酸受体表达的影响。
Front Behav Neurosci. 2020 Nov 23;14:583395. doi: 10.3389/fnbeh.2020.583395. eCollection 2020.
9
Mutations in Metabotropic Glutamate Receptor 1 Contribute to Natural Short Sleep Trait.代谢型谷氨酸受体 1 突变导致自然短睡眠特征。
Curr Biol. 2021 Jan 11;31(1):13-24.e4. doi: 10.1016/j.cub.2020.09.071. Epub 2020 Oct 15.
10
Chronic Adolescent CDPPB Treatment Alters Short-Term, but not Long-Term, Glutamatergic Receptor Expression.慢性青少年 CDPPB 治疗改变短期但不改变长期谷氨酸能受体表达。
Neurochem Res. 2018 Aug;43(8):1683-1691. doi: 10.1007/s11064-018-2584-x. Epub 2018 Jun 23.
转向精神分裂症中代谢型谷氨酸受体5(mGluR5)失调模型:对未来精神分裂症治疗的影响。
Neuropharmacology. 2017 Mar 15;115:73-91. doi: 10.1016/j.neuropharm.2015.08.003. Epub 2015 Sep 6.
4
Disruption of mGluR5 in parvalbumin-positive interneurons induces core features of neurodevelopmental disorders.小白蛋白阳性中间神经元中代谢型谷氨酸受体5的破坏会诱发神经发育障碍的核心特征。
Mol Psychiatry. 2015 Oct;20(10):1161-72. doi: 10.1038/mp.2015.113. Epub 2015 Aug 11.
5
Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia.代谢型谷氨酸受体5及其转运分子Norbin和Tamalin在精神分裂症患者海马CA1区中表达增加。
Schizophr Res. 2015 Aug;166(1-3):212-8. doi: 10.1016/j.schres.2015.05.001. Epub 2015 Jun 2.
6
Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation.精神分裂症中 mGluR5 及其内源性调节因子 Norbin、Tamalin 和 Preso1 的改变:朝向 mGluR5 失调模型。
Acta Neuropathol. 2015 Jul;130(1):119-29. doi: 10.1007/s00401-015-1411-6. Epub 2015 Mar 17.
7
Lower cortical serotonin 2A receptors in major depressive disorder, suicide and in rats after administration of imipramine.重度抑郁症、自杀及丙咪嗪给药后大鼠大脑皮质 2A 型血清素受体下调。
Int J Neuropsychopharmacol. 2014 Jun;17(6):895-906. doi: 10.1017/S1461145713001648. Epub 2014 Feb 4.
8
Perinatal phencyclidine administration decreases the density of cortical interneurons and increases the expression of neuregulin-1.围产期苯环利定给药会降低皮质中间神经元的密度,并增加神经调节蛋白-1 的表达。
Psychopharmacology (Berl). 2013 Jun;227(4):673-83. doi: 10.1007/s00213-013-2999-7. Epub 2013 Feb 5.
9
Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia.代谢型谷氨酸受体 5 在精神分裂症的发病机制和治疗中的作用。
Neurosci Biobehav Rev. 2013 Mar;37(3):256-68. doi: 10.1016/j.neubiorev.2012.12.005. Epub 2012 Dec 17.
10
Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling.代谢型谷氨酸受体二聚化在激动剂激活和 G 蛋白偶联中的独特作用。
Proc Natl Acad Sci U S A. 2012 Oct 2;109(40):16342-7. doi: 10.1073/pnas.1205838109. Epub 2012 Sep 17.